Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cortes

Showing results (161-170 of 305) with videos related to

Pageof 31
Sort By:
American Heart Journal|September 29, 1999
Long-term angiographic results of stenting in chronic total occlusions: influence of stent design and vessel sizeJ Escaned, J Cortes, M A Alcocer, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2021
Therapeutic cancer vaccines revamping: technology advancements and pitfallsG Antonarelli, C Corti, P Tarantino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.
Leukemia|October 29, 2011
Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitorsD H Mak, R-Y Wang, W D Schober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemiaS M O'Brien, H M Kantarjian, J Cortes, et al.
Cancer|July 10, 2001
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemiaJ Cortes, E Estey, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Survival of women with inflammatory breast cancer: a large population-based studyS Dawood, X Lei, R Dent, et al.
British Journal of Haematology|June 22, 2006
Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviourW Ma, H Kantarjian, S Verstovsek, et al.
Pageof 31

Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
American Heart Journal|September 29, 1999
Long-term angiographic results of stenting in chronic total occlusions: influence of stent design and vessel sizeJ Escaned, J Cortes, M A Alcocer, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2021
Therapeutic cancer vaccines revamping: technology advancements and pitfallsG Antonarelli, C Corti, P Tarantino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.
Leukemia|October 29, 2011
Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitorsD H Mak, R-Y Wang, W D Schober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemiaS M O'Brien, H M Kantarjian, J Cortes, et al.
Cancer|July 10, 2001
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemiaJ Cortes, E Estey, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Survival of women with inflammatory breast cancer: a large population-based studyS Dawood, X Lei, R Dent, et al.
British Journal of Haematology|June 22, 2006
Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviourW Ma, H Kantarjian, S Verstovsek, et al.
Pageof 31